1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
608B76A0BF9B85799652583DF0031854F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-how-medical-affairs-can-drive-successful-medical-device-product-launch-high-impact-activities-education-training-programs
18
19
2034.237.76.91
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Launch Optimization

How Medical Affairs Can Drive a Successful Medical Device Product Launch: High-Impact Launch Activities, Education & Training Programs

ID: 5555


Features:

15 Info Graphics

11 Data Graphics

170+ Metrics

13 Narratives


Pages/Slides: 35


Published: 2019


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “How Medical Affairs Can Drive a Successful Medical Device Product Launch: High-Impact Launch Activities, Education & Training Programs”

STUDY OVERVIEW

As an important conduit between medical device companies and key decision makers, the Medical Affairs function plays a significant role in the launch of a new product. From managing prominent launch activities to driving educational programs and training forums, the Medical Affairs function has to fulfill the growing demands brought on by the multiple facets of its launch role.

Best Practices, LLC undertook this benchmarking research to deliver insights into how Medical Affairs activities, operations, education and training programs can provide high-value support for the launch of device products. This study will help identify and implement more effective practices, pinpoint organizational gaps, and inform strategic planning for new medical device product launch.

KEY TOPICS

  • Most valuable Medical Affairs activities
  • Activity management
  • Effective education and training insights
  • Use and effectiveness of wet labs

KEY METRICS
  • How valuable are each of the listed Medical Affairs activities in driving the success of a new medical device product launch?
  • Which Medical Affairs sub-function manages each key activity area at your organization?
  • What are the top activity areas in which your Medical Affairs organization has driven the greatest launch impact?
  • How widely used and effective are each of the listed types of educational programs and training forums either hosted by or supported by your organization?
  • Does your organization host educational wet labs? How effective are wet labs as an educational or training program?
  • If your organization hosts educational wet labs, are these typically approved by your compliance department to be conducted only pre-approval, only post-approval, or both pre- and post- product approval?

SAMPLE KEY FINDINGS
  • Medical Affairs Launch Support Activities:
    • Medical Affairs can bring high value to product device launch via proven top-rated medical device support activities such as advisory board guidance, MSL field work, scientific publications, and clinical research – all of which are rated “highly effective” by 66% of competitors.
  • Education and Training Formats:
    • Onsite training is most common (97% of orgs use it) and effective (72% call it “highly effective”) training format. Onsite training works well for medical devices support, which is often very technical and product/procedure-based.
METHODOLOGY

Best Practices, LLC engaged 32 Medical Affairs leaders from 25 leading medical device companies in this research through a benchmarking survey. Five Medical Affairs executives were engaged in deep-dive interviews to capture additional insights.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Medical Device; Biotech; Manufacturing; Consumer Products; Biopharmaceutical; Clinical Research; Laboratories; Diversified


Companies Profiled:
Abbott; AcelRx; Alcon; Alcresta Therapeutics; Allergan; Astellas; Bausch + Lomb; Bayer; Boston Scientific; Ferring Pharmaceuticals; GE Healthcare; Gedeon Richter ; GRAIL; Innocoll; Irrimax Corporation; Medtronic; Merck; Nobel Biocare; Novartis; Nutricia; Roche Diagnostics; Sanofi; STERIS; Terumo Corporation; W.L. Gore and Associates

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.